Atlas Trials

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Clinical trial NCT04982796 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04982796
Sponsor
Portland VA Research Foundation, Inc
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Amphetamine-Related Disorders
Start date
2022-07-07
Primary completion
2026-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.